A phase 1/2 study combining ipilimumab with abiraterone acetate plus prednisone in chemotherapy- and immunotherapy-naive patients with progressive metastatic castration resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Danila, D. C.; Kuzel, T.; Cetnar, J. P.; Rathkopf, D. E.; Morris, M. J.; Alumkal, J. J.; Butler, A.; Curley, T.; Hullings, M.; Buddle, J. R.; Filipenko, J.; Scher, H. I.
Abstract Title: A phase 1/2 study combining ipilimumab with abiraterone acetate plus prednisone in chemotherapy- and immunotherapy-naive patients with progressive metastatic castration resistant prostate cancer (mCRPC)
Meeting Title: 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 15 Suppl.
Meeting Dates: 2016 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-05-20
Language: English
ACCESSION: WOS:000404711501076
DOI: 10.1200/JCO.2016.34.15_suppl.e16507
PROVIDER: wos
Notes: Meeting Abstract: e16507 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Michael Morris
    399 Morris
  2. Dana Elizabeth Rathkopf
    199 Rathkopf
  3. Howard Scher
    1047 Scher
  4. Daniel C Danila
    125 Danila
  5. Joshua Robert Buddle
    2 Buddle
  6. Alex Morgan Butler
    1 Butler